Literature DB >> 1325192

Foot-and-mouth disease virus typing by complement fixation and enzyme-linked immunosorbent assay using monovalent and polyvalent antisera.

A Alonso1, M A Martins, M da P Gomes, R Allende, M S Söndahl.   

Abstract

An indirect "sandwich" enzyme-linked immunosorbent assay (ELISA) using polyvalent and monovalent antisera was compared with the 50% complement fixation (CF50) test for the detection of foot-and-mouth disease (FMD) O, A, and C virus types. ELISA was more sensitive than CF50 tests when polyvalent antisera were used for detecting the 3 types of virus in epithelial samples, whereas ELISA using monovalent antisera was the least sensitive technique. The ELISA performed with polyvalent antisera was 9 times more sensitive for detecting FMD virus than that with monovalent antisera. However, viral isolation in cell culture was the most sensitive detection system. The combined use of ELISA with polyvalent antisera and cell culture inoculations was the most effective procedure for identifying FMD virus in epithelial samples from the field.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325192     DOI: 10.1177/104063879200400304

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  3 in total

1.  Use of the reverse transcription polymerase chain reaction (RT-PCR) for the rapid diagnosis of foot and mouth disease in South America.

Authors:  A Clavijo; P J Viera-Pereira; I Bergmann
Journal:  Vet Res Commun       Date:  2003-01       Impact factor: 2.459

2.  Degradation of foot-and-mouth disease virus during composting of infected pig carcasses.

Authors:  J Guan; M Chan; C Grenier; B W Brooks; J L Spencer; C Kranendonk; J Copps; A Clavijo
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

3.  Laboratory capacity for diagnosis of foot-and-mouth disease in Eastern Africa: implications for the progressive control pathway.

Authors:  Alice Namatovu; Sabenzia Nabalayo Wekesa; Kirsten Tjørnehøj; Moses Tefula Dhikusooka; Vincent B Muwanika; Hans Redlef Siegsmund; Chrisostom Ayebazibwe
Journal:  BMC Vet Res       Date:  2013-01-24       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.